A personal post crediting daily walks and a big shift in diet for her results on a GLP-1. One user's experience, shared on social.
Recap by typeshit. Video by Devanrenee✨ on TikTok.
Chokshi notes the sales were 0.4% of Lilly's $23 billion quarter, and that Divi's Labs hasn't announced any role in making the drug.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
She says the cause is a calorie surplus: some patients still manage high calorie foods and aren't exercising enough while on the drugs.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
BusinessWorld Online makes the case that Ozempic shouldn't be thought of as a weight loss drug. Only the headline was available, so tap through for the full argument.
Novo is putting oral treatments and more personalized options first as the market moves past raw weight loss numbers, the CEO told Chosun Ilbo.
Loading…